Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy may cause recurring hair loss due to an autoimmune response.

The document concludes that a unique target-like hair regrowth pattern in alopecia areata may be more common than thought and should be properly identified.

Topical cyclosporine led to significant hair growth in some men with male pattern baldness.

A targetoid hair regrowth pattern indicates recovery in alopecia areata.

Scalp biopsies are important for diagnosing hair loss conditions.

Some hair loss disorders cause permanent loss due to scarring, and treatments like steroids don't always work well.

The article concludes that early treatment of alopecia is crucial to prevent permanent hair loss.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Postmenopausal women may experience frontal hairline and eyebrow loss due to cicatricial fibrosis.

Primary cicatricial alopecia, a rare disorder causing permanent hair loss, is hard to diagnose and treat, with treatments like anti-inflammatory drugs and steroids offering varied results and no guaranteed cure. Psychological support for patients is important, and future research should aim to identify causes of the condition.

Hair regrowth in alopecia areata is common, but recurrences happen frequently.

Early diagnosis and aggressive treatment are crucial for Cicatricial Alopecia, and treatment effectiveness varies among patients.

The man likely has tufted folliculitis causing painful, scarring hair loss.

CCCA is a common hair loss condition in African American women, often inherited and influenced by hairstyling, with unique scalp features detectable by special tools.

Cyclosporine combination therapy can regrow hair in severe alopecia areata but needs careful monitoring for side effects.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

The document suggests that the traditional understanding of hair growth cycles and alopecia may be inaccurate and that blood supply plays a significant role in hair growth and loss.

A 36-year-old woman with worsening hair loss over 10 years was treated with various medications, and after six months, her hair loss did not worsen significantly.

Hair loss in women can be due to abnormal hair growth cycles or damaged hair follicles, with the most common type being androgenetic alopecia; treatment varies by cause, and the psychological impact is significant.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

The treatment for alopecia areata with diphenylcyclopropenone was unsuccessful.

Effective hair loss treatment requires personalized approaches and patient-provider collaboration.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Alopecia in the woman was likely caused by vitamin A deficiency, not a fungal infection.

Patients with certain types of hair loss often experience emotional and mental health issues.